Amphastar Pharma slips on deal to buy Eli Lilly's low blood sugar drug

Amphastar Pharmaceuticals,

24/04/2023 15:14

** Amphastar Pharmaceuticals Inc  AMPH.O  shares down 5.5% at
$41.4 
    ** Eli Lilly and Co  LLY.N  will sell its low blood sugar
drug Baqsimi to Amphastar in a deal worth up to $1.08 billion
 urn:newsml:reuters.com:*:nL4N36R27L
    ** Amphastar will pay $500 million at closing and another
$125 million in cash after one year under the deal
    ** Up to last close, AMPH rose 56.5%

 (Reporting by Nandhini Srinivasan in Bengaluru)
 ((nandhini.srinivasan@thomsonreuters.com))